Crinetics Pharmaceuticals Inc
(CRNX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Sales | 442 | 535 | 640 | 832 | 45 |
| Gross Profit | 442 | 530 | 640 | 832 | 45 |
| Operating Expenses | 5,968 | 3,049 | 3,014 | 2,475 | 2,654 |
| Operating Income | -5,526 | -2,514 | -2,374 | -1,643 | -2,609 |
| Interest Expense | 0 | -7 | 2 | 3 | 2 |
| Other Income | 62 | -30 | -6 | -2 | 5 |
| Pre-tax Income | -5,464 | -2,537 | -2,382 | -1,648 | -2,606 |
| Net Income Continuous | -5,464 | -2,537 | -2,382 | -1,648 | -2,606 |
| Net Income | $-5,464 | $-2,537 | $-2,382 | $-1,648 | $-2,606 |
| EPS Basic Total Ops | -2.92 | -1.61 | -1.67 | -1.22 | -2.18 |
| EPS Basic Continuous Ops | -2.92 | -1.62 | -1.67 | -1.22 | -2.18 |
| EPS Diluted Total Ops | -2.92 | -1.61 | -1.67 | -1.22 | -2.18 |
| EPS Diluted Continuous Ops | -2.92 | -1.62 | -1.67 | -1.22 | -2.18 |
| EBITDA(a) | $-5,478 | $-2,474 | $-2,346 | $-1,618 | $-2,582 |